###begin article-title 0
###xml 72 80 <span type="species:ncbi:9606">Children</span>
Serum TNF-Alpha Level Predicts Nonproliferative Diabetic Retinopathy in Children
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 486 491 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 814 819 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 953 958 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 993 998 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1140 1145 1124 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1248 1253 1228 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 152 160 <span type="species:ncbi:9606">children</span>
###xml 185 193 <span type="species:ncbi:9606">children</span>
###xml 328 336 <span type="species:ncbi:9606">children</span>
###xml 576 581 <span type="species:ncbi:9606">Human</span>
###xml 632 640 <span type="species:ncbi:9606">children</span>
###xml 1184 1192 <span type="species:ncbi:9606">patients</span>
The aim of this study was identification of the immunologic markers of the damage to the eye apparatus at early stages of diabetes mellitus (DM) type 1 children. One hundred and eleven children with DM type 1 were divided into two groups: those with nonproliferative diabetic retinopathy (NPDR) and without retinopathy. All the children had their daily urine albumin excretion, HbA1c, C-peptide measured, 24-hour blood pressure monitoring, and ophthalmologic examination. Levels of TNF-alpha, IL-6, and IL-12 in serum were measured by ELISA tests (Quantikine High Sensitivity Human by R&D Systems, Minneapolis, Minn, USA). The NPDR children demonstrated a significantly longer duration of the disease in addition to higher HbA1c, albumin excretion rate, C-reactive protein, systolic blood pressure, as well as TNF-alpha and IL-6 levels than those without retinopathy. The logistic regression revealed that the risk of NPDR was strongly dependent on TNF-alpha [(OR 4.01; 95%CI 2.01-7.96)]. TNF-alpha appears to be the most significant predictor among the analyzed parameters of damage to the eye apparatus. The early introduction of the TNF-alpha antagonists to the treatment of young patients with DM type 1 who show high serum activity of the TNF-alpha may prevent them from development of diabetic retinopathy.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1131 1132 1131 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1133 1134 1133 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1299 1300 1299 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1430 1435 1430 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1564 1565 1560 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1566 1568 1562 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1575 1580 1571 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1699 1700 1691 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1702 1703 1694 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1799 1801 1791 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 188 196 <span type="species:ncbi:9606">patients</span>
###xml 620 628 <span type="species:ncbi:9606">children</span>
###xml 904 912 <span type="species:ncbi:9606">children</span>
###xml 1731 1735 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1943 1951 <span type="species:ncbi:9606">children</span>
Diabetic retinopathy usually does not occur during the first five years from the diagnosis of diabetes mellitus (DM) type 1, whilst after 10 years of diabetes it is present in over 50% of patients, being the most common cause of loss of vision [1]. Regardless numerous studies carried out worldwide, daily urine albumin secretion remains to be standard marker of nephropathy development, while ophthalmologic examination stands for diagnosis of retinopathy [2, 3]. Presently, there is no satisfactory pharmacologic therapy and laser therapy remains to be the leading treatment option in management of DM1 retinopathy in children. Yet still the therapy is aimed at limiting the damage and not at preventing it [3, 4]. Early detection of the individual tendency for development of diabetic retinopathy, especially before evident changes become visible at the fundus of the eye, is extremely significant in children and adolescent with DM type 1. Most of the published works focus on the role of cytokines in the development of proliferative retinopathy in adults, thus such analysis is limited to the late stages of the retinopathy [5-8]. It has been suggested that hyperglycemia may lead to the activation of proinflammatory cytokines that are crucial for development and progression of retinopathy [9, 10]. One of the glucose toxic mechanisms, the protein glycation, is associated with cytokines: tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-12 (IL-12) that are substantial factors in the development of diabetic microangiopathy [9-11]. TNF-alpha and IL-6 may act as local intensification signals in pathological processes associated with chronic eye inflammation [5, 6]. It has been shown in NOD-mice that also IL-12 is associated with rapid diabetes development [12]. Therefore, the purpose of this work was the identification of the early immunologic markers of the damage to the eye apparatus in diabetic children.
###end p 4
###begin title 5
2. PATIENTS AND METHODS
###end title 5
###begin p 6
###xml 303 305 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 307 309 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 23 31 <span type="species:ncbi:9606">children</span>
One hundred and eleven children (age 15 +/- 2 years) with DM type 1 were recruited from The Diabetological Department, Clinic of Pediatrics, Hematology, Oncology and Endocrinology Medical University of Gdansk. Type 1 DM, was defined in accordance with the criteria of the American Diabetes Association [13, 14].
###end p 6
###begin title 7
3. LABORATORY EXAMINATIONS
###end title 7
###begin p 8
###xml 356 364 <span type="species:ncbi:9606">children</span>
###xml 1122 1130 <span type="species:ncbi:9606">patients</span>
HbA1c was measured by an immunoturbidometric method using Unimate 3 set (Hoffmann-La Roche AG, Germany) with a normal range of values 3.0-6.0%. Fasting glucose was measured by enzymatic test (Roche Diagnostics GmbH, Germany). Level of CRP was measured with immunochemical system (Beckman Instr. Inc., Ireland). Level of C-peptide was below 0.5ng/ml in all children with type 1 DM. The systolic and diastolic blood pressures were measured using automatic 24-hour ambulatory blood pressure monitoring (ABPM) and all the average values of the blood pressure were expressed in the centile charts. The urinary albumin excretion was expressed as the average of the three 24-hour collections obtained during 6 months prior to the enrolment into the study. Classified as microalbuminuria were the cases when at least in two out of three urine samples albumin excretion was between 30-299 mg/24 hours. The urinary albumin excretion is measured by immunoturbidometric assay using Tina-quant (Boehringer Mannheim GmbH, Germany). Serum level of creatinine was measured using CREA assay system (Boehringer Mannheim GmbH, Germany). All patients with type 1 DM required insulin treatment (0.87 +/- 0.24 U/kg of the body weight).
###end p 8
###begin title 9
4. OPHTHALMOLOGIC EXAMINATION
###end title 9
###begin p 10
###xml 7 15 <span type="species:ncbi:9606">children</span>
In all children with type 1 DM the ophthalmologic investigation was performed. This included visual acuity tests, intraocular pressure, and anterior segment estimation done by slit lamp (TOPCON SL-82, Japan). The fundus examination was done after installation of 1% Tropicamid to obtain sufficient mydriasis. The examination was performed by using the +90D lens (Ocular Instruments Inc., Bellevue, Wash, USA). Digital camera (Topcon IMAGEnet 2000 Japan) was used to perform the fluorescein angiography.
###end p 10
###begin p 11
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 291 299 <span type="species:ncbi:9606">children</span>
###xml 358 366 <span type="species:ncbi:9606">children</span>
###xml 396 404 <span type="species:ncbi:9606">children</span>
###xml 508 516 <span type="species:ncbi:9606">children</span>
###xml 600 608 <span type="species:ncbi:9606">children</span>
###xml 670 678 <span type="species:ncbi:9606">children</span>
The analysis of the eye fundus pictures was based on The International Diabetic Retinopathy Division: 1) nonproliferative retinopathy with or without maculopathy, 2) preproliferative retinopathy, 3) proliferative retinopathy [15]. According to the ophthalmological examination, the diabetic children were divided into 2 groups: with diabetic retinopathy (21 children) and without retinopathy (90 children). In 21 cases, typical symptoms of nonproliferative diabetic retinopathy were proven. Additionally, 16 children of the group with nonproliferative diabetic retinopathy had microalbuminuria and 7 children were presented with arterial hypertension, while none of the children without retinopathy presented clinical signs of diabetic nephropathy such as microalbuminuria or arterial hypertension.
###end p 11
###begin p 12
###xml 22 30 <span type="species:ncbi:9606">children</span>
###xml 202 210 <span type="species:ncbi:9606">children</span>
A group of 41 healthy children (age 14 +/- 2 years) volunteered as the control group. They were apparently healthy as based on their medical examination. Written, informed consent was obtained from all children (or from their parents) participating in the study. This study was approved by The Ethics Committee of The Medical University of Gdansk NKEBN/610/2003/2004 and the investigation was carried out in accordance with the principles of the Declaration of Helsinki as revised in 1996.
###end p 12
###begin title 13
5. SAMPLE COLLECTION
###end title 13
###begin p 14
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 43 51 <span type="species:ncbi:9606">children</span>
Plasma samples were collected from the 152 children. Blood samples were immediately placed on ice, clarified by centrifugation at 3.000 x g for 5 minutes at 4degreesC, and kept frozen at -80degreesC until assay.
###end p 14
###begin title 15
###xml 24 29 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
6. DETERMINATION OF TNF-alpha, IL-6, IL-12 LEVELS
###end title 15
###begin p 16
###xml 30 35 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 357 362 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 421 426 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 123 128 <span type="species:ncbi:9606">Human</span>
Serum levels of cytokines TNF-alpha IL-6, IL-12 were measured by immunoenzymatic ELISA method (Quantikine High Sensitivity Human by R&D Systems, Minneapolis, Minn., USA) according to manufacturer protocol. Minimum detectable concentrations were determined by the manufacturer as 0.12 pg/ml, 0.03 pg/ml, and 1.0 pg/ml, respectively. Intra-assay (2.6 for TNF-alpha; 1.6 for IL-6; 1.1 for IL-12) and interassay (7.4 for TNF-alpha; 6.4 for IL-6; 7.1 for IL-12) precision performances of the assays were determined on 20 replicates from the quality control data of the laboratory.
###end p 16
###begin title 17
7. STATISTICAL ANALYSIS
###end title 17
###begin p 18
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
The results were analyzed using The Statistical Version 7.0 program (StatSoft Polska ). The Shapiro-Wilk test was used to evaluate normality of variables. The differences between the groups were calculated with Student t or the nonparametric U-Mann-Whitney tests.
###end p 18
###begin p 19
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A logistic forward regression analysis was used to assess the association between all clinical and inflammatory parameters and retinopathy with a P < .05 for entry. Risk for retinopathy was estimated by odds ratios (ORs) with 95% confidence intervals (CIs).
###end p 19
###begin p 20
###xml 7 8 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 160 161 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 228 229 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 9 15 <span type="species:ncbi:9606">person</span>
###xml 80 88 <span type="species:ncbi:9606">children</span>
The chi2 person test was applied for calculating differences between numbers of children with and without detectable cytokines in serum. The results of Student t test were presented as arithmetic means +/-SD. The results of the U-Mann-Whitney test were presented as median (min-max). In all analyses a two-tailed significance level <.05 was regarded as statistically significant.
###end p 20
###begin title 21
8. RESULTS
###end title 21
###begin p 22
###xml 539 546 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 9 17 <span type="species:ncbi:9606">children</span>
###xml 349 357 <span type="species:ncbi:9606">children</span>
The NPDR children demonstrated a significantly longer duration of the disease in addition to higher HbA1c, albumin excretion rate, C-reactive protein, as well as systolic blood pressure than those without retinopathy. There were no significant differences between both groups in the serum creatinine and diastolic blood pressure. Moreover, the NPDR children demonstrated a significantly higher HbA1c, C reactive protein, albumin excretion rate, creatinine in serum, systolic and diastolic blood pressures as compared to the healthy group (Table 1).
###end p 22
###begin p 23
###xml 24 29 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 382 387 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 462 469 454 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 105 113 <span type="species:ncbi:9606">children</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 306 314 <span type="species:ncbi:9606">Children</span>
The serum levels of TNF-alpha and IL-6 in the group with NPDR were significantly higher as compared with children without retinopathy. On the other hand, the IL-12 levels were higher in the NPDR group with regard to the patients without retinopathy, however the difference was statistically insignificant. Children without retinopathy were characterized by significantly higher TNF-alpha, IL-6, as well as IL-12 serum levels in relation to the healthy controls (Table 2).
###end p 23
###begin p 24
###xml 72 77 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 135 140 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 265 270 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 27 35 <span type="species:ncbi:9606">children</span>
###xml 296 304 <span type="species:ncbi:9606">children</span>
###xml 381 389 <span type="species:ncbi:9606">children</span>
###xml 445 453 <span type="species:ncbi:9606">children</span>
###xml 691 699 <span type="species:ncbi:9606">children</span>
As many as 76% of the NPDR children had a detectable serum level of TNF-alpha while in the group without retinopathy only 34% were TNF-alpha positive. This stands in clear contrast to the healthy group which was absolutely (100%) negative with respect to serum TNF-alpha. The differences between children with and without NPDR were statistically significant. However, all the NPDR children (100%) had a detectable serum level of IL-6 and 70% of children without retinopathy were IL-6 positive. The differences between both diabetic groups were statistically significant. In the healthy group only 2.85% were IL-6 positive. There were no differences between percentages of the IL-12 positive children in the groups with NPDR and without retinopathy, 43% and 24%, respectively.
###end p 24
###begin p 25
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 79 87 <span type="species:ncbi:9606">children</span>
Results of the factors predisposing to diabetic retinopathy development in DM1 children are summarized in Table 3.
###end p 25
###begin title 26
9. DISCUSSION
###end title 26
###begin p 27
###xml 377 382 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 524 529 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 32 40 <span type="species:ncbi:9606">children</span>
###xml 86 94 <span type="species:ncbi:9606">children</span>
###xml 201 209 <span type="species:ncbi:9606">children</span>
###xml 417 425 <span type="species:ncbi:9606">children</span>
###xml 459 467 <span type="species:ncbi:9606">children</span>
We have examined a group of 111 children diagnosed with DM type 1, including 21 (26%) children with recognised nonproliferative diabetic retinopathy. In relation to those without retinopathy, the NPDR children demonstrated significantly longer duration of the disease, they had higher HbA1c, urine albumin excretion rate, CRP level, as well as the systolic blood pressure. TNF-alpha was detectable in 76% of the NPDR children and only in 34% of the DM type 1 children without retinopathy. Statistical analysis disclosed TNF-alpha as the only independent early marker indicating occurrence of changes at the fundus of the eye.
###end p 27
###begin p 28
###xml 75 80 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 201 203 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 204 206 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 364 366 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 390 395 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 519 524 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 769 774 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 827 829 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 886 891 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 950 952 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 97 105 <span type="species:ncbi:9606">children</span>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
###xml 252 260 <span type="species:ncbi:9606">children</span>
###xml 450 458 <span type="species:ncbi:9606">children</span>
###xml 583 591 <span type="species:ncbi:9606">children</span>
###xml 687 695 <span type="species:ncbi:9606">Children</span>
In a few studies published in recent years authors reported detectable TNF-alpha in the serum of children with long-standing diabetes, however these patients had no concomitant diabetic complications [16-19]. The Chinese scientists analyzed a group of children of less than 5 years of diabetes mellitus type 1 duration having no late complications of the disease [17]. They showed that TNF-alpha serum levels did not differ from those of the healthy children. The Italian group reported results of a study in which TNF-alpha and IL-6 serum levels were compared between the groups of children being less than one year or over five years from the DM type 1 diagnosis and healthy controls. Children being less than one year form the disease diagnosis presented higher TNF-alpha serum levels in comparison to the other two groups [18]. On the other hand a different group reported that TNF-alpha serum level was found lower than in the healthy controls [19].
###end p 28
###begin p 29
###xml 21 26 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 249 250 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 252 254 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 390 392 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 488 493 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 512 513 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 514 516 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 907 908 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 910 912 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 914 916 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
The mechanism of TNF-alpha contribution to diabetic retinopathy is not fully elucidated. It has been suggested that hyperglycaemia may lead to the activation of proinflammatory cytokines that are crucial for micro- and macroangiopathy developments [9, 10]. In diabetic patients an increased synthesis of the macrophage's RAGE receptors, which bind final glycation products, has been noted [10]. The RAGE receptors signalize the proinflammatory cytokines' cascade induction, including TNF-alpha, IL-6, and IL-12 [9-11]. These cytokines may mediate the synthesis of acute phase proteins which are able to initiate and support inflammatory process in the vascular wall. As a consequence, an increased expression of intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1) on endothelial cells is induced, which serves as chemoattractants for monocytes and other inflammatory cells [1, 11, 20].
###end p 29
###begin p 30
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 801 806 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1003 1005 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1046 1048 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1050 1052 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1262 1264 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 87 95 <span type="species:ncbi:9606">children</span>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">children</span>
###xml 767 775 <span type="species:ncbi:9606">children</span>
###xml 1038 1044 <span type="species:ncbi:9606">humans</span>
In our study serum IL-6 level was more elevated in NDPR group than without retinopathy children and similar relations concerned the IL-6 positive sera in these groups. On the other hand, IL-6 did not reach a status of an independent retinopathy risk factor. The negative role of IL-6 is also associated with its effect on endothelial dysfunction with an increased permeability and enhanced expression of adhesion molecules on these cells [18, 21, 22]. Elevated levels of IL-6 both in serum and in vitreous fluid have been detected in proliferative retinopathy in adult patients [23, 24]. However, there was no report published in the available literature on the role of IL-6 at the early stages of the diabetic retinopathy development in DM type 1 children. The NPDR children, apart from elevated TNF-alpha and IL-6 levels, did not differ in the IL-12 concentration. Formerly, the role of IL-12 as a proinflammatory cytokine in the insulin-dependent diabetes pathogenesis was shown using the NOD model [12] and in some limited studies in humans [25, 26]. Winkler et al. showed that IL-12 may also contribute to the pathogenesis of diabetic retinopathy more likely as a part of the consecutive immunological response mechanisms rather than a predisposing factor [26].
###end p 30
###begin p 31
###xml 89 94 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 195 200 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
On the account of the presented data it appears that, among the analyzed parameters, TNF-alpha is the most significant predictor of damage to the eye apparatus. The early introduction of the TNF-alpha antagonists to the treatment of young patients with DM type 1 who show high serum activity of the cytokine may prevent development of diabetic retinopathy.
###end p 31
###begin title 32
ACKNOWLEDGMENTS
###end title 32
###begin p 33
This paper was presented during the 16th European Congress of Immunology in Paris, France, 2006. This work was supported by the Medical University of Gdansk, Poland (ST-28, ST-8, and ST-56).
###end p 33
###begin title 34
ABBREVIATIONS
###end title 34
###begin p 35
Diabetes mellitus
###end p 35
###begin p 36
Nonproliferative diabetic retinopathy
###end p 36
###begin p 37
Tumor necrosis factor-alpha
###end p 37
###begin p 38
Interleukin-6
###end p 38
###begin p 39
Interleukin-12
###end p 39
###begin p 40
Ambulatory blood pressure monitoring
###end p 40
###begin p 41
Receptor for advanced glycation end product
###end p 41
###begin p 42
Intercellular adhesion molecule-1
###end p 42
###begin p 43
Vascular adhesion molecule-1
###end p 43
###begin article-title 44
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study
###end article-title 44
###begin article-title 45
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study
###end article-title 45
###begin article-title 46
Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy
###end article-title 46
###begin article-title 47
###xml 119 121 119 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1c</sub>
Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c)
###end article-title 47
###begin article-title 48
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Cytokines in the vitreous of patients with proliferative diabetic retinopathy
###end article-title 48
###begin article-title 49
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases
###end article-title 49
###begin article-title 50
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy
###end article-title 50
###begin article-title 51
###xml 28 33 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 39 43 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus
###end article-title 51
###begin article-title 52
###xml 27 29 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1c</sub>
Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes
###end article-title 52
###begin article-title 53
###xml 131 139 <span type="species:ncbi:9606">patients</span>
Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy
###end article-title 53
###begin article-title 54
###xml 187 192 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 241 244 <span type="species:ncbi:10116">rat</span>
Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli
###end article-title 54
###begin article-title 55
###xml 111 115 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice
###end article-title 55
###begin article-title 56
Report of the expert committee on the diagnosis and classification of diabetes mellitus
###end article-title 56
###begin article-title 57
Follow-up report on the diagnosis of diabetes mellitus
###end article-title 57
###begin article-title 58
Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11
###end article-title 58
###begin article-title 59
###xml 10 14 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 61 69 <span type="species:ncbi:9606">children</span>
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
###end article-title 59
###begin article-title 60
###xml 79 87 <span type="species:ncbi:9606">children</span>
The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus
###end article-title 60
###begin article-title 61
###xml 28 36 <span type="species:ncbi:9606">children</span>
Endothelial perturbation in children and adolescents with type 1 diabetes
###end article-title 61
###begin article-title 62
###xml 42 47 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 78 86 <span type="species:ncbi:9606">children</span>
Low serum levels of tumor necrosis factor-alpha in insulin-dependent diabetic children
###end article-title 62
###begin article-title 63
Biochemical and molecular mechanisms of diabetic retinopathy
###end article-title 63
###begin article-title 64
New markers of inflammation and endothelial cell activation-part I
###end article-title 64
###begin article-title 65
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease
###end article-title 65
###begin article-title 66
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema
###end article-title 66
###begin article-title 67
Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema
###end article-title 67
###begin article-title 68
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro
###end article-title 68
###begin article-title 69
Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus
###end article-title 69
###begin p 70
###xml 37 45 <span type="species:ncbi:9606">children</span>
Clinical parameters of the DM type 1 children and healthy group. Values are presented as means +/- SD.
###end p 70
###begin p 71
###xml 21 29 <span type="species:ncbi:9606">children</span>
*Differences between children with nonproliferative retinopathy and without retinopathy.
###end p 71
###begin p 72
###xml 22 30 <span type="species:ncbi:9606">children</span>
**Differences between children with nonproliferative retinopathy and healthy group.
###end p 72
###begin p 73
###xml 54 62 <span type="species:ncbi:9606">children</span>
Circulating levels of cytokines in serum of DM type 1 children and healthy group. Values are presented as means +/- SD.
###end p 73
###begin p 74
###xml 21 29 <span type="species:ncbi:9606">children</span>
*Differences between children with nonproliferative retinopathy and without retinopathy.
###end p 74
###begin p 75
###xml 22 30 <span type="species:ncbi:9606">children</span>
**Differences between children with nonproliferative retinopathy and healthy group.
###end p 75
###begin p 76
Unadjusted retinopathy risk gradation.
###end p 76

